BRIEF published on 07/22/2025 at 09:05, 7 months 28 days ago Gut Microbiome: A Potential Early Indicator of Dementia Risk Early Detection Screening Tools Gut Microbiome Dementia Risk MCI Prediction
PRESS RELEASE published on 07/22/2025 at 09:00, 7 months 28 days ago Study Findings Reveal: Gut Microbiome May Offer Early Insight into Dementia Risk Study reveals gut microbiome may offer early insight into dementia risk, potentially leading to screening tools for routine diagnostics and early interventions. SYNLAB expert co-authors findings Alzheimer's Disease Early Detection SYNLAB Gut Microbiome Dementia Risk
BRIEF published on 07/01/2025 at 09:05, 8 months 18 days ago VαMPiRE Project Makes Strides in Parkinson’s Detection EU Funding Parkinson’s Detection VαMPiRE Project SYNLAB Diagnostics Α-synuclein Biomarkers
PRESS RELEASE published on 07/01/2025 at 09:00, 8 months 18 days ago Milestone Reached in Groundbreaking Project for Early Detection of Parkinson’s Disease SYNLAB reaches a milestone in the VαMPiRE project funded by the EU, focusing on early Parkinson's disease detection with advanced genomics and €8 million funding Parkinson's Disease Diagnostic Test EU Funding SYNLAB VαMPiRE Project
BRIEF published on 10/30/2024 at 07:37, 1 year 4 months ago Cinven Acquires Elliott's Stake in SYNLAB AG with Squeeze-Out Imminent Private Equity Squeeze-out SYNLAB AG Cinven Elliott Advisors
PRESS RELEASE published on 10/30/2024 at 07:32, 1 year 4 months ago Cinven to Acquire Elliott’s Stake in SYNLAB AG, Squeeze-Out to Follow Cinven acquires Elliott's stake in SYNLAB AG, squeeze-out procedure initiated. SYNLAB's Management Board informed. Ephios Bidco to hold over 96% share capital Private Equity SYNLAB AG Cinven Elliott Squeeze Out
BRIEF published on 09/17/2024 at 16:05, 1 year 6 months ago Cinven to Sell Minority Stake in SYNLAB to Labcorp Investment SYNLAB Cinven Labcorp Minority Stake
PRESS RELEASE published on 09/17/2024 at 16:00, 1 year 6 months ago Cinven to sell minority stake in SYNLAB to strategic investor Labcorp Cinven agrees to sell 15% stake in SYNLAB to Labcorp, a global leader in laboratory services. Transaction aims to enhance lab efficiency and customer experience Strategic Investor Medical Diagnostics SYNLAB Cinven Labcorp
BRIEF published on 06/04/2024 at 20:51, 1 year 9 months ago Cybersecurity Incident at Synnovis in UK Cybersecurity SYNLAB Synnovis NHS England Impact
PRESS RELEASE published on 06/04/2024 at 20:46, 1 year 9 months ago Cybersecurity Incident at Synnovis in UK SYNLAB AG confirms cybersecurity incident at Synnovis in the UK, isolated from previous attacks. Taskforce working to assess impact and minimize disruptions for patients and partners SYNLAB AG Synnovis NHS England Cybersecurity Incident Patient Impact
Published on 03/20/2026 at 03:10, 2 hours 50 minutes ago Future Fuels Announces Filing of Amended and Restated Life Offering Document
Published on 03/20/2026 at 00:20, 5 hours 40 minutes ago Prospect Ridge To Host Investor Webinar With Presentation And Audience Q&A
Published on 03/20/2026 at 00:20, 5 hours 40 minutes ago Reeflex Solutions Inc. Announces Revocation of Management Cease Trade Order
Published on 03/19/2026 at 21:16, 8 hours 44 minutes ago Unusual Machines, Inc. Announces Proposed Public Offering
Published on 03/19/2026 at 14:20, 15 hours 40 minutes ago CBMJ CEO Rips Legacy Liberal Media Over Iran Coverage on The Schaftlein Report
Published on 03/20/2026 at 03:05, 2 hours 55 minutes ago HEROAD Unleashes a New Era of Gaming: Professional-Grade Gear Meets Unbeatable Value
Published on 03/19/2026 at 23:48, 6 hours 12 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C daily buy back notice
Published on 03/19/2026 at 22:55, 7 hours 5 minutes ago Baristas behind millions of cups of coffee compete globally
Published on 03/19/2026 at 22:48, 7 hours 12 minutes ago EQS-Adhoc: Forecast for the 2026 financial year
Published on 03/19/2026 at 08:45, 21 hours 15 minutes ago Deezer and Sonos renew and expand long-term collaboration
Published on 03/19/2026 at 07:00, 23 hours ago bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
